This federal Indefinite Delivery Contract (IDC) was awarded by the Veterans Integrated Service Network 16, a civilian agency under the Department of Veterans Affairs (VA), to Preventiongenetics LLC, a for-profit limited liability company specializing in advanced genetic testing services. The contract has a ceiling value of $1,719,533.16 and a period of performance through June 1, 2030. The primary purpose of this IDC is to provide TESTING SERVICES FOR LAB SAMPLES to support the VA's healthcare...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) to Laboratory Corporation of America (LabCorp) for comprehensive medical laboratory testing and analysis services to support its Veterans Integrated Service Network (VISN) 9. Under this IDV contract, LabCorp will provide a wide range of diagnostic testing capabilities, including reference laboratory testing, genomic screening, specimen transport, and connectivity...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Infinity Biologix LLC, doing business as Sampled Division, for genomic analysis services worth up to $86.5 million over the period of performance ending September 29, 2025. This single-award IDC was issued by the VA Headquarters and does not include any socioeconomic set-asides. Under this IDC, the VA has issued multiple firm-fixed-price delivery orders to Infinity Biologix for genomic sequencing, DNA...
The Department of Veterans Affairs (VA) awarded a 5-year Blanket Purchase Agreement (BPA) to Neogenomics Laboratories, Inc. to provide specialized reference laboratory testing services, including genetic testing, flow cytometry, and diagnostic pathology, in support of veteran healthcare across the VA medical network. The $75,000 BPA enables the VA to directly order required diagnostic testing and analysis on an as-needed basis to support personalized medicine and care for veterans. Additionally,...
The U.S. Department of Veterans Affairs (VA) awarded a $130.7 million Indefinite Delivery Contract (IDC) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services, for specialized tumor molecular profiling services. This single-award IDC, with a completion date of September 12, 2029, aims to provide the VA's National Precision Oncology Program with comprehensive genomic profiling for both solid and hematological malignancies. The contracted services...
This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) to Ambry Genetics Corporation, a subsidiary of Konica Minolta Healthcare Americas, Inc. The contract has a ceiling value of $2,085,930 and a period of performance through March 28, 2026. Ambry Genetics is providing specialized genetic reference laboratory testing services to support various VA healthcare programs. The contracted services include a range...
The Department of Veterans Affairs (VA) awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract to Foundation Medicine, Inc., a foreign-owned for-profit organization, for genomic sequencing testing services. The potential contract value exceeds $111 million and does not utilize any set-aside designations. Under this IDIQ contract, Foundation Medicine has been awarded multiple firm fixed price delivery orders to provide a range of genomic sequencing, next-generation sequencing (NGS),...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a single-award indefinite delivery contract to Naveris Inc., a for-profit organization located in Waltham, Massachusetts, for NAVDX blood testing services. The contract, valued at a ceiling of $968,000.00, has an ultimate completion date of April 30, 2026. Two task orders have been issued under the IDC so far. The first task order, valued at $176,000.00, has a completion date of April 30, 2025 and is for NAVDX...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick, a civilian agency, to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The $99,032,828.20 multiple-award IDC provides national access to germline genetic testing for oncology, medical genetics, and pharmacogenomic testing for VA patients through September 2029. The IDC includes a $2,300,000 fixed-price task order for "GERMLINE PGX...
The Department of Veterans Affairs (VA) Headquarters has awarded Akesogen, Inc.'s Tempus Labs division a $111 million indefinite delivery contract to provide genomic analysis services in support of the agency's Million Veteran Program biomedical research initiative. This single-award IDV, originally granted in 2020, facilitates the issuance of firm-fixed-price delivery orders for Tempus Labs to conduct genomic sequencing, DNA quality assessment, SNP genotyping, methylation analysis, and other...